Published in J Thromb Haemost on May 22, 2009
Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood (2010) 1.17
Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem (2012) 0.92
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies. J Am Coll Cardiol (2015) 0.78
The SCHOOL of nature: III. From mechanistic understanding to novel therapies. Self Nonself (2010) 0.77
Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke. Int J Stroke (2016) 0.75
Clustering of GPVI dimers upon adhesion to collagen as a mechanism to regulate GPVI signalling in platelets. J Thromb Haemost (2017) 0.75
Modified platelet deposition on matrix metalloproteinase 13 digested collagen I. J Thromb Haemost (2015) 0.75
Direct evidence of a native GPVI dimer at the platelet surface. J Thromb Haemost (2009) 0.75
Use of oligodeoxynucleotide signature probes for identification of physiological groups of methylotrophic bacteria. Appl Environ Microbiol (1990) 3.79
SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem (2000) 3.20
Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15
Localization of specificity determining sites in cadherin cell adhesion molecules. Cell (1990) 2.99
The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum (1996) 2.28
Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem (1976) 2.07
Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res (1995) 2.07
Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest (1978) 1.79
Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity (2000) 1.74
Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum (1998) 1.69
Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus. J Mol Cell Cardiol (2001) 1.67
Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med (2001) 1.66
Comparison of limulus amebocyte lysates and correlation with the United States Pharmacopeial pyrogen test. Appl Environ Microbiol (1977) 1.63
IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus. N Engl J Med (1981) 1.57
Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest (2000) 1.56
Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res (2003) 1.47
IgG heavy chain allotypes (Gm) in autoimmune diseases. Clin Exp Immunol (1980) 1.46
Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol (1999) 1.45
HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol (1988) 1.43
Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol (2014) 1.40
Effect of obstructive jaundice on neutrophil chemotactic activity: an in vivo assessment in zymosan-induced peritonitis model in rats. J Gastroenterol Hepatol (1998) 1.40
Tissue-specific mosaicism for trisomy 21 and congenital heart disease. J Pediatr (1992) 1.40
Liquid nitrogen preservation of Saccharomyces carlsbergensis and its use in a rapid biological assay of vitamin B6 (pyridoxine). Appl Microbiol (1966) 1.38
Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol (1996) 1.38
Phylogenetic study of the species within the family Streptomycetaceae. Antonie Van Leeuwenhoek (2011) 1.34
Loss of the 3p25.3 band is critical in the manifestation of del(3p) syndrome: karyotype-phenotype correlation in cases with deficiency of the distal portion of the short arm of chromosome 3. Am J Med Genet (1990) 1.32
HLA antigens in Kawasaki disease. Pediatrics (1978) 1.31
The behavior of alpha2-plasmin inhibitor in fibrinolytic states. J Clin Invest (1977) 1.31
Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology (2001) 1.31
Changes in cell surface antigen expressions during proliferation and differentiation of human erythroid progenitors. Blood (1992) 1.24
Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol (1998) 1.24
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci U S A (1995) 1.24
Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture. J Exp Med (1988) 1.20
Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas (2003) 1.19
CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages. Blood (2001) 1.18
Temporal bone studies of the human peripheral vestibular system. Normative vestibular hair cell data. Ann Otol Rhinol Laryngol Suppl (2000) 1.18
Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant (2000) 1.17
Platelets interact with soluble and insoluble collagens through characteristically different reactions. J Biol Chem (1998) 1.17
The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity (1997) 1.16
In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity (1998) 1.16
Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood (1998) 1.16
Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha(2)beta(1). J Biol Chem (2000) 1.16
Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood (1997) 1.15
Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. Int Immunol (1992) 1.14
Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A (1999) 1.13
Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol (1991) 1.12
Translocation breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum Mol Genet (1997) 1.12
Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy. Am J Clin Pathol (1979) 1.12
Stability of microcystins from cyanobacteria: effect of light on decomposition and isomerization. Environ Sci Technol (1994) 1.12
Temporal bone studies of the human peripheral vestibular system. Normative Scarpa's ganglion cell data. Ann Otol Rhinol Laryngol Suppl (2000) 1.12
Dry-heat destruction of lipopolysaccharide: dry-heat destruction kinetics. Appl Environ Microbiol (1978) 1.12
Gm allotypes in myasthenia gravis. Lancet (1980) 1.11
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest (1993) 1.10
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J Exp Med (1996) 1.10
Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem (2001) 1.10
Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature (1986) 1.10
Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. J Clin Endocrinol Metab (1993) 1.09
Biodegradation of low-molecular-weight halogenated hydrocarbons by methanotrophic bacteria. FEMS Microbiol Rev (1990) 1.09
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology (1992) 1.08
Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues. J Bone Miner Res (2001) 1.08
HLA antigens and myasthenia gravis in Japan. J Neurol Sci (1977) 1.08
[Studies on the anti-hemorrhagic substances in herbs classified as hemostatics in Chinese medicine. X. On hemostatic activities of the parched herbs for hemostatics]. Yakugaku Zasshi (1989) 1.08
Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes (1993) 1.08
Entrainment of the circadian activity rhythm to the light cycle: effective light intensity for a Zeitgeber in the retinal degenerate C3H mouse and the normal C57BL mouse. Physiol Behav (1980) 1.07
Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood (1999) 1.07
Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol (1993) 1.07
"Mitotic drive" of expanded CTG repeats in myotonic dystrophy type 1 (DM1). Hum Mol Genet (2001) 1.06
Sterility test method for petrolatum-based ophthalmic ointments. Appl Microbiol (1970) 1.06
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. Thromb Haemost (1978) 1.06
Liquid nitrogen preservation of Saccharomyces carlsbergensis and its use in a rapid biological assay of pantothenic acid. Appl Microbiol (1966) 1.06
Terminal 22q deletion associated with a partial deficiency of arylsulphatase A. J Med Genet (1992) 1.05
Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol (1995) 1.04
Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol (1995) 1.04
Automated turbidimetric bioassay readout instrument using a multiple flow-cell system. Appl Microbiol (1967) 1.04
Strain differences of the mouse's free-running circadian rhythm in continuous darkness. Physiol Behav (1978) 1.04
Permanent Genetic Resources added to Molecular Ecology Resources database 1 January 2009-30 April 2009. Mol Ecol Resour (2009) 1.04
Inhibitory spectrum of alpha 2-plasmin inhibitor. Proc Natl Acad Sci U S A (1979) 1.03
Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol (1995) 1.03
Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J Cell Biochem (2003) 1.03
Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. J Endocrinol (2003) 1.02
Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells. J Immunol (1989) 1.02
Endothelin-1- and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci (1992) 1.02
HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens (1992) 1.01
Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer. J Natl Cancer Inst (1981) 1.00
Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells. J Exp Med (1996) 1.00
Dexamethasone enhances SOX9 expression in chondrocytes. J Endocrinol (2001) 0.99
Study on the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. IV. Structures of chimaerol and sodium chimaerol sulfate in the bile of Lamna ditropis and Rhizoprionodon acutus. Chem Pharm Bull (Tokyo) (1994) 0.99
The low pH species of bacteriorhodopsin. Structure and proton pump activity. FEBS Lett (1979) 0.99
High-performance liquid chromatographic determination of erythromycin. J Chromatogr (1978) 0.98
Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol (1997) 0.98
Expression of MAGE genes in human colorectal carcinoma. Ann Surg (1996) 0.98
Laparoscopic splenectomy for a lymphangioma of the spleen: report of a case. Surg Today (2001) 0.98
A counting method of maximum likelihood for estimating haplotype frequency in the HL-A system. Jinrui Idengaku Zasshi (1975) 0.97
Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5. Am J Med Genet (1991) 0.97
Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation. Bone Marrow Transplant (2003) 0.97
Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood (1996) 0.97